Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

O. Lada · SciRah

Researcher profile · Semantic Scholar

O. Lada

Share profile

O. Lada — researcher profile on SciRah

h-index: 19
Works: 63
Citations: 1,930

Most-cited papers

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa‐2a in HBeAg‐negative patients
R. Moucari, V. Mackiewicz, O. Lada, M. Ripault +10 more
2009Hepatology484 citations Open access
Semantic Scholar
IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.
T. Asselah, S. De Muynck, P. Broët, J. Masliah-Planchon +15 more
2012Journal of Hepatology189 citations
Semantic Scholar
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.
R. Moucari, A. Korevaar, O. Lada, M. Martinot-Peignoux +10 more
2009Journal of Hepatology189 citations
Semantic Scholar
Coexistence of Hepatitis B Surface Antigen (HBs Ag) and Anti-HBs Antibodies in Chronic Hepatitis B Virus Carriers: Influence of “a” Determinant Variants
O. Lada, Y. Benhamou, T. Poynard, V. Thibault
2006Journal of Virology168 citations Open access
Semantic Scholar
Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C
A. Cardoso, R. Carvalho-Filho, C. Stern, A. Dipumpo +10 more
2012Liver international (Print)152 citations
Semantic Scholar
In Vitro Susceptibility of Lamivudine-Resistant Hepatitis B Virus to Adefovir and Tenofovir
O. Lada, Y. Benhamou, A. Cahour, C. Katlama +2 more
2003Antiviral Therapy122 citations Open access
Semantic Scholar
Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients.
M. Martinot-Peignoux, R. Carvalho-Filho, M. Lapalus, Ana Carolina Ferreira Netto-Cardoso +5 more
2013Journal of Hepatology114 citations
Semantic Scholar
Clinically Relevant Genotype Interpretation of Resistance to Didanosine
A. Marcelin, P. Flandre, J. Pavie, N. Schmidely +5 more
2005Antimicrobial Agents and Chemotherapy88 citations Open access
Semantic Scholar
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
M. Martinot-Peignoux, M. Lapalus, C. Laouénan, O. Lada +6 more
2013Journal of Clinical Virology82 citations
Semantic Scholar
Reduction of MicroRNA 122 Expression in IFNL3 CT/TT Carriers and during Progression of Fibrosis in Patients with Chronic Hepatitis C
E. Estrabaud, M. Lapalus, P. Broët, K. Appourchaux +9 more
2014Journal of Virology29 citations Open access
Semantic Scholar
IFNL3 (IL28B) polymorphism does not predict long‐term response to interferon therapy in HBeAg‐positive chronic hepatitis B patients
Q. Zhang, M. Lapalus, T. Asselah, C. Laouénan +10 more
2014Journal of Viral Hepatitis29 citations
Semantic Scholar
Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B
M. Lapalus, C. Laouénan, A. Cardoso, E. Estrabaud +10 more
2015Liver international (Print)27 citations
Semantic Scholar
Interferon therapy for chronic hepatitis B.
T. Asselah, O. Lada, R. Moucari, M. Martinot +2 more
2007Clinical Liver Disease27 citations
Semantic Scholar
Comparison of Tests and Procedures to Build Clinically Relevant Genotypic Scores: Application to the Jaguar Study
P. Flandre, A. Marcelin, J. Pavie, Nathalie Shmidely +5 more
2005Antiviral Therapy25 citations Open access
Semantic Scholar
Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS).
S. Pol, Fayssoil Fouad, M. Lemaitre, I. Rodriguez +4 more
2021The Lancet Regional Health - Europe23 citations Open access
Semantic Scholar
Chronic hepatitis B: back to the future with HBsAg
R. Moucari, O. Lada, P. Marcellin
2009Expert Review of Anti-Infective Therapy23 citations Open access
Semantic Scholar
Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin
S. Larrat, S. Vallet, S. David-Tchouda, A. Caporossi +39 more
2015Journal of Clinical Microbiology22 citations Open access
Semantic Scholar
Quasispecies Analysis and In Vitro Susceptibility of HBV Strains Isolated from HIV–HBV-Coinfected Patients with Delayed Response to Tenofovir
O. Lada, A. Gervais, M. Branger, G. Peytavin +8 more
2012Antiviral Therapy21 citations
Semantic Scholar
Clevudine: a promising therapy for the treatment of chronic hepatitis B
T. Asselah, O. Lada, R. Moucari, P. Marcellin
2008Expert Opinion on Investigational Drugs20 citations
Semantic Scholar
Long‐term outcome of primary non‐responders to tenofovir therapy in HIV/HBV‐co‐infected patients: impact of HBV genotype G
O. Lada, A. Gervais, M. Branger, G. Peytavin +8 more
2012Liver international (Print)17 citations
Semantic Scholar
Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudine
P. Marcellin, O. Lada, T. Asselah
2007Hepatology Research15 citations
Semantic Scholar
IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C
E. Estrabaud, K. Appourchaux, I. Bièche, F. Carrat +7 more
2015PLoS ONE9 citations Open access
Semantic Scholar
Using Pharmacokinetic and Viral Kinetic Modeling To Estimate the Antiviral Effectiveness of Telaprevir, Boceprevir, and Pegylated Interferon during Triple Therapy in Treatment-Experienced Hepatitis C Virus-Infected Cirrhotic Patients
C. Laouénan, P. Marcellin, M. Lapalus, F. Khelifa-Mouri +14 more
2014Antimicrobial Agents and Chemotherapy8 citations Open access
Semantic Scholar
532 SIGNIFICANT GENOTYPE-SPECIFIC ASSOCIATION OF HEPATITIS B SURFACE ANTIGEN LEVEL AND SEVERITY OF LIVER DISEASE IN PATIENTS WITH CHRONIC HEPATITIS B
M. Martinot-Peignoux, R. Carvalho-Filho, A. C. Ferreira, N. Cardoso +5 more
20127 citations
Semantic Scholar
[Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
P. Marcellin, O. Lada
2006Gastroentérologie Clinique et Biologique5 citations
Semantic Scholar
[Treatment of chronic hepatitis B].
T. Asselah, O. Lada, N. Boyer, M. Martinot +1 more
2004Gastroentérologie Clinique et Biologique5 citations
Semantic Scholar
IFI 35 , mir-99 a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C
E. Estrabaud, K. Appourchaux, I. Bièche, F. Carrat +8 more
20194 citations
Semantic Scholar
Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims database.
Benjamin Rolland, N. Hallouche, O. Lada, Pascaline Rabiéga +3 more
2024Psychiatry Research3 citations
Semantic Scholar
PIN151 PATIENTS TREATED FOR HEPATITIS C: AN OBSERVATIONAL STUDY WITH THE FRENCH ADMINISTRATIVE HEALTH CARE DATABASE (SNDS)
S. Pol, I. Rodríguez, F. Fouad, M. Lemaitre +3 more
2019Value in Health3 citations Open access
Semantic Scholar
A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy
C. Laouénan, J. Guedj, G. Peytavin, Thi Huyen Tram Nguyen +15 more
2014CPT: Pharmacometrics & Systems Pharmacology3 citations Open access
Semantic Scholar
Chronic hepatitis B
T. Asselah, O. Lada, R. Moucari, P. Marcellin
20123 citations
Semantic Scholar
The Experiences with Reengineering Using Computer Simulation
F. Manlig, O. Lada, F. Koblasa
20113 citations Open access
Semantic Scholar
[Treatment of chronic hepatitis B].
T. Asselah, O. Lada, P. Marcellin
2011La Revue du praticien3 citations
Semantic Scholar
529 WEEK 12 HBSAG TITER DECLINE IS PREDICTIVE OF SVR IN CHRONIC HEPATITIS B PATIENTS RECEIVING PEGYLATED INTERFERON PLUS TENOFOVIR COMBINATION THERAPY
P. Marcellin, M. Martinot-Peignoux, M. Lapalus, O. Lada +3 more
20122 citations
Semantic Scholar
782 HEPATIC MIRNA SIGNATURE PREDICTING SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C
E. Estrabaud, I. Bièche, M. Lapalus, S. De Muynck +8 more
20112 citations
Semantic Scholar
Benefits associated with HCV cure in people with mental disorders
B. Rolland, Elias Benabadji, O. Lada, P. Rabiéga +3 more
2022Journal of Hepatology1 citations
Semantic Scholar
Treating patients with DAAs helped to save €1 billion in France - a budget impact model from 2014 to 2018
H. Leleu, I. Rodríguez, M. Blachier, O. Lada +2 more
2020Journal of Hepatology1 citations Open access
Semantic Scholar
P776 REDUCTION OF MIR-122 IN IFNL3 CT+TT CARRIERS AND DURING PROGRESSION OF FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C
E. Estrabaud, M. Lapalus, P. Broët, K. Appourchaux +9 more
20141 citations
Semantic Scholar
754 QUASISPECIES ANALYSIS OF HBV STRAINS ISOLATED FROM CHRONIC HEPATITIS B PATIENTS TREATED WITH PEG-INTERFERON+ TENOFOVIR THERAPY
O. Lada, Q. Zhang, M. Lapalus, C. La'eounan +5 more
20131 citations
Semantic Scholar
447 IL28B POLYMORPHISM IS NOT ASSOCIATED WITH RESPONSE TO CONVENTIONAL INTERFERON TREATMENT AND HBSAG SEROCLEARANCE IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS
O. Lada, Q. Zhang, M. Lapalus, Rami Moucari +9 more
20121 citations
Semantic Scholar
783 DIFFERENTIAL LIVER MIRNAS EXPRESSION IN CHRONIC HEPATITIS C PATIENTS AT EARLY STAGES OF LIVER FIBROSIS
E. Estrabaud, I. Bièche, M. Lapalus, S. De Muynck +8 more
20111 citations
Semantic Scholar
684 LIVER GENE EXPRESSION SIGNATURE TO PREDICT RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C
A. Ducès, I. Bièche, Bénédicte Jardin-Watelet, M. Lapalus +17 more
20101 citations
Semantic Scholar
Emergency transplantation for acute reactivation of chronic hepatitis B with high viral load: role of antiviral therapy
R. Moucari, C. Francoz, O. Lada, Wael Abdel Razek +4 more
2009Liver international (Print)1 citations
Semantic Scholar
695 LOW RATE OF DELAYED RESPONSE IN LAMIVUDINE EXPERIENCED HIV/HBV CO-INFECTED PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)
O. Lada, A. Gervais, M. Branger, G. Peytavin +6 more
20081 citations
Semantic Scholar
1164 susceptibility of wild-type and lamivudine-resistant hepatitis B virus to tenofovir and adefovir
O. Lada, Y. Benhamou, M. Valantin, C. Katlama +3 more
20031 citations
Semantic Scholar
Impact of Extending DAA Availability in France: A Five-Year Overview (2015-2019) of Data From French Administrative Healthcare Databases (SNDS)
S. Pol, Fayssoil Fouad, M. Lemaitre, I. Rodriguez +2 more
2021Social Science Research Network0 citations Open access
Semantic Scholar
Patients treated for hepatitis C: an observational study with the French administrative healthcare database (SNDS)
S. Pol, I. Rodríguez, O. Lada, Fayssoil Fouad +2 more
2020Journal of Hepatology0 citations Open access
Semantic Scholar
P0626 : The analysis of the expression of A2M, COL1A1, MMP2 and CHI3L identifies significant fibrosis in patients with chronic hepatitis B
E. Estrabaud, R. Carvalho-Filho, O. Lada, C. Laouénan +7 more
20150 citations
Semantic Scholar
Virus-Infected Cirrhotic Patients in Treatment-Experienced Hepatitis C Pegylated Interferon during Triple Therapy Effectiveness of Telaprevir , Boceprevir , and Modeling To Estimate the Antiviral Using Pharmacokinetic and Viral Kinetic
M. Lapalus, F. Khelifa-Mouri, N. Boyer, F. Zoulim +12 more
20140 citations
Semantic Scholar
1149 REDUCTION OF mir-122 EXPRESSION IN IL28B CT/TT CHRONIC HEPATITIS C PATIENTS WHO FAILED TO PEGYLATED-INTERFERON PLUS RIBAVIRIN TREATMENT
E. Estrabaud, M. Lapalus, P. Broët, S. De Muynck +9 more
20130 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Marcellin×32
Invite
P. Marcellin — researcher profile on SciRah
T. Asselah×28
Invite
T. Asselah — researcher profile on SciRah
M. Martinot-Peignoux×26
Invite
M. Martinot-Peignoux — researcher profile on SciRah
M. Lapalus×20
Invite
M. Lapalus — researcher profile on SciRah

×17

Invite

N. Boyer — researcher profile on SciRah

Invite

M. Vidaud — researcher profile on SciRah

E. Estrabaud×14

Invite

E. Estrabaud — researcher profile on SciRah

Invite

P. Bedossa — researcher profile on SciRah

Invite

I. Bièche — researcher profile on SciRah

Invite

R. Moucari — researcher profile on SciRah

S. De Muynck×9

Invite

S. De Muynck — researcher profile on SciRah

C. Laouénan×7

Invite

C. Laouénan — researcher profile on SciRah